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Background: The liver has a crucial role in metabolic homeostasis as well as being the principal detoxification
centre of the body, removing xenobiotics and waste products which could potentially include some nanomaterials
(NM). With the ever increasing public and occupational exposure associated with accumulative production of
nanomaterials, there is an urgent need to consider the possibility of detrimental health consequences of
engineered NM exposure. It has been shown that exposure via inhalation, intratracheal instillation or ingestion can
result in NM translocation to the liver. Traditional in vitro or ex vivo hepatic nanotoxicology models are often
limiting and/or troublesome (i.e. reduced metabolism enzymes, lacking important cell populations, unstable with
very high variability, etc.).
Methods: In order to rectify these issues and for the very first time we have utilised a 3D human liver microtissue
model to investigate the toxicological effects associated with a single or multiple exposure of a panel of
engineered NMs (Ag, ZnO, MWCNT and a positively charged TiO2).
Results: Here we demonstrate that the repeated exposure of the NMs is more damaging to the liver tissue as in
comparison to a single exposure with the adverse effects more significant following treatment with the Ag and
ZnO as compared with the TiO2 and MWCNT NMs (in terms of cytotoxicity, cytokine secretion, lipid peroxidation
and genotoxicity).
Conclusions: Overall, this study demonstrates that the human microtissue model utilised herein is an excellent
candidate for replacement of traditional in vitro single cell hepatic models and further progression of liver
nanotoxicology.
Keywords: 3D human liver microtissue, Engineered nanomaterials, Inflammation, Lipid peroxidation, GenotoxicityBackground
The rapid expansion of technological, scientific and com-
mercial uses of molecular scale materials, their assembly
and their unique properties has led to an escalating
interest in the fields of nanoscience, nanotechnology and
nanomedicine [1]. There are now over 1600 consumer
products on the market with a claim of containing aspects
of nanotechnology [2]. These applications include medicine,* Correspondence: alke@sund.ku.dk
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article, unless otherwise stated.electronics, engineering, cosmetics and textiles [3]. As a
negative however, the same unique chemical and physical
characteristics which make NMs so desirable might also
contribute to their potential adverse effects, which raises
concerns that some NMs could be hazardous for people
living and working with said materials [4,5]. The small size
of particulate nanomaterials results in a high surface area
to volume ratio, which potentially offers a greater bio-
logical activity per given mass compared to larger-size ma-
terials [6]. In addition to this, the surface reactivity per
unit surface area can be greater at the nano-scale due to
higher curvature of the surface [7]. As the potential for
public and occupational exposure is likely to rise withCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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need to consider the possibility of detrimental health con-
sequences of engineered NMs of all kinds. The health risk
is assessed based upon the level of exposure to the NM,
toxicity of the material in question, route of exposure and
the persistence of the particular material in the organism.
The lungs and the gastrointestinal tract are in constant
contact with the external environment, hence these sys-
tems are the primary exposure sites for NMs [5,8]. How-
ever it has been demonstrated that some NMs can
translocate from these primary exposure sites [8,9]. As a
secondary exposure site the liver is extremely important,
as it has been shown to accumulate NMs at much higher
concentrations compared to other organs [8-11]. In addi-
tion, the prominent advances in nanomedicine will result
in an increase in direct entry of NMs into the circulatory
system. The presence of NMs in the blood will result in
the materials reaching the liver faster and in large quan-
tities and will cause the induction of an immune response
from the organ [12-15].
The liver has a crucial role in metabolic homeostasis.
It is responsible for the storage, synthesis, metabolism
and/or redistribution of carbohydrates and fats [16]. The
organ produces large numbers of serum proteins, an
array of enzymes and acute phase proteins. It is also the
principal detoxification centre of the body, removing
foreign substances and waste products [16]. The liver is
characterised by its distinct populations of cells, each
with their own unique morphology amongst which the
hepatocytes, the resident macrophage population (Kupffer
cells - KCs) and sinusoidal endothelial cells (SECs) being
of utmost importance due to their numbers, location
within a healthy liver and the wide arrays of functions that
are crucial in overall liver activity [13,14,16-19].
It is widely argued that in vitro hepatocyte systems (in-
cluding cell lines and systems without optimal artificial
extracellular matrices) might not be ideal for functional
and metabolic studies as the cells lose key liver specific
functions especially their cytochrome P450 (CYP450) ac-
tivity [18,20,21]. Hence the cells used in such experiments
are not representative of “real” hepatocytes in vivo. In
addition, most hepatic studies of the effects of nanomater-
ials are undertaken on hepatocyte cell lines or primary
cultures lacking any non-parenchymal cells. However
these cells are extremely important as they are compo-
nents of the reticulo-endothelial system and are involved
in the clearance of particles from blood as well as being
crucial in the initiation of an immune response to foreign
material challenge. Finally, in typical in vitro or ex-vivo
systems cells have a very limited life span, therefore the
opportunity for repeated exposure is not usually possible.
To address all above issues for the very first time in a
study of its kind we have utilized the InSphero 3D human
liver microtissue model generated from primary humanhepatocytes and liver-derived non-parenchymal cells [22,23]
in order to investigate the adverse effects of a panel of
engineered NMs as a model of the human liver.
The panel of NMs chosen for this study were part of
the Joint Research Centre (JRC) repository for nanoma-
terials. These materials included a zinc oxide (ZnO), a
silver (Ag), a multi-walled carbon nanotube (MWCNT)
and a positively charged titanium dioxide (TiO2), which
are currently incorporated in numerous products includ-
ing sunscreens, cosmetics, sporting goods and anti-
bacterials [2].
This study therefore investigated the toxicological prop-
erties of the panel of four engineered nanomaterials on
the human liver microtissue following a single or multiple
(five) exposures. Here the materials and the tissue were
fully characterised before NM induced cell cytotoxicity, in-
flammatory response (cytokine secretion), oxidative stress
(lipid peroxidation), DNA damage and hepatic function
(albumin production) were investigated.
Results
Characteristics of pristine and dispersed nanomaterials
The investigated NMs were extensively characterised by
a combination of analytical techniques in order to infer
primary physical and chemical properties useful to
understand their toxicological behaviour. A list of the
measured physical and chemical properties of selected
nanomaterials was previously described and has been
reproduced in Table 1 [24]. In order to investigate how
the NM characteristics are affected in human liver main-
tenance medium, the hydrodynamic size distributions of
the NMs was measured after dispersion in the medium
(5-20 μg/ml range) (Table 1).
Microtissue characterisation
In order to evaluate the applicability of heterotypic 3D
human liver microtissues for prolonged, repeated nano-
material exposure, the morphological characterization of
the microtissues was performed. To investigate the 3D
cytoarchictecture and the histological phenotype, the hu-
man liver microtissues were stained with Hemalaun and
Eosin (H&E) (Figure 1A). The H&E staining indicates
the presence of typcial liver histotypic features, such as a
cuboidal hepatocyte cell shape with tight cell-cell con-
tacts. These features are preserved over the tested cul-
ture period. The microtissues were 7 days old at first
treatment time (0 hr in Table 2). The data presented
here is representative of span of 21 days demonstrating
healthy tissues over the whole assay period. The absence
of a necrotic core suggests that sufficient oxygen and
nutrients are transported into the inner regions of the
microtissue. Since the primary hepatocytes are co-
cultured with primary non-parenchymal cells, the pres-
ence of KC was tested with macrophage specific marker
Table 1 Main physical and chemical properties of tested NMs (adapted and reproduced from 24)
NM code NM type Phase XRD size [nm] TEM size Surface area
(BET) [m2/g]





NM 110 ZnO Zincite 70 to >100 20-250/50-350 14 None 130 ± 48 (64%) 23.36-46.70%
242 ± 32 (25%)
NM 300 Ag Ag 7$ 8-47 (av. 17.5) NA PVP capped 98 ± 43 <1%
14£
<18
NM 400 MWCNT - - D: 5-35 298 None NA NA
L: 700-3000
NRCWE 002 TiO2 Rutile 10 80-400 84 Triethylpropylaminosaline 278 ± 151 NA
$wet XRD in capillary tube.
£dried samples.
Ψintensity based size average in biological media within 30 mins.
Abbreviations: D Diameter, L Length, XRD X-ray diffraction.
Kermanizadeh et al. Particle and Fibre Toxicology 2014, 11:56 Page 3 of 15
http://www.particleandfibretoxicology.com/content/11/1/56CD68 (Figure 1B). The immunohistochemistry analysis
shows that KCs are indeed incorporated into the micro-
tissues and present troughout the tested culture period.
In addtion some KCs were found to be loosly attached
to the microtissue. The cells show a typical dynamic
morphology with both elongated and rounded cell
shapes. Here we were unable to identify significant num-
bers of SECs in the selected microtissues following the
incorporation of the particular batch of non paranchmal
cells.Figure 1 Morphological characterization of intact 3D human liver mic
fixed paraffin embedded microtissues after 7 and 28 days in culture. Two rImpact of the selected panel of NMs on human
microtissue membrane integrity
From the adenylate kinase (AK) data it was evident that
there was a concentration-dependent decrease in cell
membrane integrity over time following a single and re-
peated exposure of the NMs (Figure 2). These effects
were more apparent after the repeated exposures al-
though they only became statistically significant for the
ZnO and Ag NMs at the later time points (p < 0.05 –
240, 312 and 360 hr exposure) (Figure 2B and D). It isA
B
rotissue. A) H&E staining B) CD68 immunohistochemistry of formalin
epresentative tissues are shown per time point (magnification 200×).
Table 2 Microtissue maintenance and NM treatment in the singular and repeated exposure experiments over a period
of 15 days
Single exposure End-points investigated
Treatment 1 – 0 hr (day 0) -
Change medium – 24 hr (day 1) AK assay, cytokine secretion, albumin
Change medium – 72 hr (day 3) Albumin
Change medium – 168 hr (day 7) AK assay, cytokine secretion
Change medium – 216 hr (day 9) Albumin
Change medium – 264 hr (day 11) -
Change medium – 336 hr (day 14) -
Change medium – 360 hr (day 15) AK assay, cytokine secretion, lipid peroxidation, DNA damage, albumin
Multiple exposure End-points investigated
Treatment 1 – 0 hr (day 0) -
Change medium – 24 hr (day 1) – 48 hr recovery period AK assay, cytokine secretion
Treatment 2 – 72 hr (day 3) AK assay, cytokine secretion, albumin
Change medium – 96 hr (day 4) - 48 hr recovery period AK assay, cytokine secretion, albumin
Treatment 3 – 144 hr (day 6) AK assay, cytokine secretion
Change medium – 168 hr (day 7) - 48 hr recovery period AK assay, cytokine secretion, albumin
Treatment 4 – 216 hr (day 9) AK assay, cytokine secretion, albumin
Change medium – 240 hr (day 10) - 48 hr recovery period AK assay, cytokine secretion, albumin
Treatment 5 – 288 hr (day 12) -
Change medium – 312 hr (day 13) AK assay, cytokine secretion
Change medium – 360 hr (day 15) Lipid peroxidation, DNA damage, albumin
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of the NMs at the any of the time-points or doses inves-
tigated here. Finally, no NM interference was noted with
this assay. In addition, live/dead staining of microtissue
further supported the AK data depicting increasing cell
death following repeated exposure to the panel of nano-
materials over time (Figure 3).
Cytokine secretion from liver microtissue following
treatment with four engineered NMs
Changes in cytokine production as a consequence of NM
exposure were assessed within the supernatant of exposed
human liver microtissue and quantified via BD™ Cytomet-
ric Bead Array cytokine flex sets. The levels of human
interleukin (IL) IL1β, IL8, IL10, interferon-γ (IFN-γ) and
tumour necrosis factor-α (TNF-α) were measured. IL8 is a
chemokine mediating the activation and migration of a
wide variety of inflammatory cells including neutrophils
into tissue, hence playing a pivotal role in initiation of an
inflammatory response [25]. IL10 is a multi-functional
cytokine with diverse effects on a wide range of hema-
topoietic cells. The cytokine’s principle function is to ter-
minate inflammatory responses [26,27]. IL10 also plays a
key role in differentiation of regulatory T cells, which fig-
ure prominently and importantly in the control of immune
responses and developing a tolerant immune state [26].For the single exposure experiments a concentration
dependent increase in IL8 and IL10 was observed. This
increase was most evident 24 hr post exposure with these
levels dropping over time and returning to background
control levels after 360 hr post exposure (Figure 3A and
B). Additionally, no significant difference was observed
between the NMs. It was discovered that repeated expos-
ure to the NMs resulted in additional secretion of IL8 and
IL10 from the tissue at the later time-points although
these levels did not reach those of the initial exposure in
most instances (24 hr) (Figure 3C and D). Additionally,
statistically (p < 0.05) significant differences were found at
the latter time-points between the NMs with higher levels
of both cytokines following exposure to the Ag and ZnO
NMs.
Finally, we noted very small amounts of TNF-α and
IFN-γ secreted from the microtissue following repeated
exposures of the Ag and NM ZnO NM at the latter time
points (data not shown), while no IL1β was detected for
any of the NMs, doses or time-points investigated here.
Lipid peroxidation measurements
Lipid peroxidation which is essential as a means of asses-
sing oxidative stress was quantified following the single or
repeated exposures of the four engineered NMs. Interest-




Figure 2 Cytotoxicity in human liver microtissue following a single or repeated exposures of a panel of engineered nanomaterials. The
microtissue were exposed to cell medium (control)/or NMs over a period of 360 hr as measured by AK release and measured via ToxiLight™
cytotoxicity assay. Values represent mean ± SEM (n = 3). Single exposure A) ZnO C) Ag E) MWCNT G) TiO2. Repeated exposure (0, 72, 144, 216 and
288 hr) B) ZnO D) Ag F) MWCNT H) TiO2.
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any NMs (Figure 4). As a contrast however repeated ex-
posure to the ZnO and Ag NMs at the higher concentra-
tions (ZnO - 4 and 8 μg/ml and Ag - 2, 4 and 8 μg/ml)
resulted in significantly higher levels of TBARS from the
exposed tissue (Figure 4A and B) while no changes were
noted for the MWCNT or TiO2 NMs.
DNA damage
In order to investigate the level of DNA damage caused
by a single or repeated exposure of the engineered NMs
the comet assay was utilised. A significant increase in
DNA strand breaks was noted following exposure to the
higher concentrations of all four NMs with the Ag and
ZnO being most DNA damaging (Figure 5). In addition,
the strand breaks were most evident following the re-
peated exposure as in comparison to the single exposures.The net level of Fpg sensitive sites (Fpg treatment minus
basal level of strand breaks) for the 8 μg/ml exposure was
3.77 ± 1.33% tail DNA (single exposure) and 7.04 ± 1.83%
tail DNA (repeated exposures), which were higher than
the respective controls (1.32 ± 0.46 and 0.99 ± 0.39, re-
spectively, p < 0.05 significance for repeated exposure).
This indicates that the damage witnessed is partially due
to oxidative damage to DNA following exposure to these
NMs (Figure 5B). The positive control (Ro19-8022 plus
white light) had substantially higher levels of Fpg sensitive
sites (21.65 ± 1.52% tail DNA) than the liver microtissue.
Impact of engineered NMs on albumin production by
human liver microtissue
In order to establish whether any of the NMs affected al-
bumin production two concentrations were chosen which
were representative of a higher and a low dose for the four
B CA
E FD
Figure 3 Live/dead staining of human liver microtissue at 240 hr post repeated exposure. A) Control B) four treatments of ZnO (NM 110)
NM at 8 μg/ml C) four treatments of Ag (NM 300) NM at 8 μg/ml D) four treatments of MWCNT (NM 400) NM at 125 μg/ml E) four treatments of
TiO2 (NRCWE 002) NM at 125 μg/ml F) 0.5% Triton-× 100 (24 hr – positive control). As a note the microtissue treated with the MWCNT was partially
covered with the NMs hence the quality of the image is inferior to the rest.
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and 125 μ/ml for the TiO2 and MWCNT NMs). There
were no significant alterations at any of the investi-
gated time-points following the single exposure of four
NMs (Figure 6A). However the repeated exposure of ZnO
NM at 4 μg/ml resulted in a significant decrease of albu-
min production from the liver microtissue at the two latest
time-points investigated (Figure 6B). The repeated expos-
ure of three other materials at these concentrations and
time-points did not alter albumin production from the
liver microtissue in this study.CYP3A4 levels
Basal hepatic CYP3A4 activity was examined in the liver
microtissues over the time span of the experiments
(Figure 7). Midazolam was used as an accepted probe
substrate to quantify the enzymatic activity of CYP3A4,
the main responsible cytochrome for xenobiotic metab-
olism [28,29]. Interestingly, we found no decrease in the
metabolic enzyme activity of CYP3A4 over the entire
period of NM treatment, which highlights the suitabilityof this model system for long-term exposures of nano-
materials Figure 8.Discussion
This particular study focused on the toxicological impact
of a panel of four engineered nanomaterials on a 3D hu-
man liver microtissue model with respect to toxicity, up-
regulation of pro/anti-inflammatory mediators, oxidative
stress, genotoxicity and hepatic function. This is the first
study of its kind that incorporates this new technology
in a nanotoxicological context. In this study we demon-
strate that the repeated exposure of the NMs is more
damaging to the liver tissue as in comparison to a single
exposure with the adverse effects more significant fol-
lowing treatment with the Ag and ZnO NMs in terms of
cytotoxicity, cytokine secretion, lipid peroxidation and
genotoxicity.
Hepatocytes constitute the major cellular compartment
of the liver (approximately up to 70% of total liver). These
cells are involved in almost all functions that are attributed
to the liver. They play a substantial role in the metabolism
A B
C D
Figure 4 IL8 and IL10 secretion of human liver microtissue following single and repeated exposure of a panel of engineered NMs. The
tissues were exposed to cell medium control or NMs over a period of 360 hr. Values represent mean ± SEM (n = 3). A) IL8 secretion following a
single exposure of a panel of engineered NMs B) IL10 secretion following a single exposure of a panel of engineered NMs C) IL8 secretion
following the repeated exposure of a panel of engineered NMs D) IL10 secretion following the repeated exposure of a panel of engineered NMs.
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blood-derived protein [16]. Hepatocytes manufacture im-
portant serum proteins such as complement components
and acute phase proteins [16], as well as numerous hor-
mones and cytokines [30-32].
KCs are the resident macrophages of the liver. These
cells represent the largest number of macrophages in the
mammalian body. KCs eliminate antigens from the cir-
culation and are responsible for the clearance of gut-
derived bacteria [16-19]. These macrophages are usually
concentrated in the periportal region of the liver, which
allows monitoring of the blood entering the organ [16].
It is believed that due to the constant exposure to low
levels of gut-derived antigens, KCs are in a permanent
semi-activated state. Similarly to other macrophages,
once these KCs are fully activated they are capable of
aggressive phagocytosis and antigen uptake and the
production of an array of mediators involved in pro-
tein degradation, cytotoxicity and defence mechanisms
[33-35]. KCs are also extremely important in the main-
tenance of liver tolerance (in which the organ does not
mount an immune response to the antigen) [19]. It is
understood that following the initial activation and pro-
duction of a pro-inflammatory response, KCs release IL10which down-regulates the production pro-inflammatory
cytokines [14,19].
SECs (3% of total liver volume) form an important filtra-
tion barrier between macromolecules (might also include
NMs) and blood cells and hepatocytes – preventing direct
contact and influencing the extent of exchange of various
substances [16,36].
As already mentioned, nanomaterials entering the blood
stream will accumulate within the liver [8,37,38]. In
addition, advances in the field of nanomedicine will no
doubt result in an increase in direct entry of NMs into the
circulatory system. The NMs designed specifically for drug
delivery are generally developed to have specific surface
properties which influence the fate in the body, including
increasing blood circulation time [39,40]. The presence of
these NMs in the blood allows distribution to a wide range
of target organs, increasing the likelihood of the accumu-
lation of materials in the liver.
In this study NM induced cytotoxicity was evaluated
utilizing the ToxiLight™ bioassay kit which measures
adenylate kinase release from cells with damaged
membranes. AK is an enzyme present in all eukaryotic
cells which plays a critical role in intracellular energy
homeostasis. From the AK membrane integrity data a
A B
C D
Figure 5 The effects of increasing concentration of NMs on lipid peroxidation of human liver microtissue. The tissue was exposed to cell
medium (control) or NMs on single or multiple occasions. The data is presented as mean TBARS (nmol/mg tissue) (± SEM) from three experiments
(n = 3), significance indicated by * = p < 0.05 and ** = p < 0.005, when NM treatments are compared to the control. A) ZnO NMs B) Ag NMs C) MWCNT
NMs D) TiO2 NMs.
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damage was noted over time following the single and
repeated exposure of the NMs. The prolonged observa-
tion time up to 360 hr allowed detection of toxicity after
very low single exposures where the usual 3-24 hr assays
would show no effect. The adverse effects were more
apparent after the repeated exposures, with the toxicity
being higher for ZnO and Ag NMs at the later time
points. It is important to note that an LC50 was not
reached for any of the NMs at any of the time-points or
doses investigated here. The doses in this study were
selected as they represented acute sub-lethal doses from
previous studies in a hepatocyte cell line [24] and human
primary hepatocytes [31]. It is interesting that multiple
exposures to low concentrations of NMs (in particular
for the Ag and ZnO NM) resulted in increased cytotox-
icity over time which can be attributed to the internal-
isation and accumulation of materials within the cells.
This is extremely important as the accumulation of NMs
might account for any potential toxicity that might occur
following human exposure scenarios and might be more
representative of realistic in vivo scenarios and bring up
questions about the relevance of acute in vitro single cell
type toxicity studies at least for the purpose of riskassessment. It also seems appropriate to mention the im-
portance of the in vitro dose selection as a representative
of realistic in vivo exposure [41,42]. In this particular study
an in vitro dose of 8 μg/ml was the highest dose for ZnO
and Ag exposure. Although this dose might be high with
regards to the lung burden which might be reached after
inhalation exposure [41,43,44], it is a relatively low dose in
the context of an in vitro study. Having said this, a life time
of exposure or IV administration of nano drugs might result
in similar doses reaching the liver in vivo. Furthermore, it
has been shown that in vitro studies can be a good indicative
of in vivo response dependant on the NM and the investi-
gated specific outcome [15,17,45]. It should be noted that
we are aware that the repeated dose exposures utilised in
this study for the TiO2 and MWCNT are high and in all
reality would not be reached in in vivo settings. However we
believed it important to use the same sub-lethal doses in
order to allow for the continuation of previous in vitro
studies. This also permitted for the validation of the new
technology in a nanotoxicological context.
Next, IL1β, IL8, IL10, IFN-γ and TNF-α secretion was
measured as a means of evaluating NM induced pro/
anti-inflammatory response from the human liver micro-
tissue. Firstly, it was discovered that IL8 and IL10 were
A B
C D
Figure 6 DNA damage expressed as percentage of tail DNA following exposure of the human liver microtissue to single or repeated
exposure of engineered NMs. The tissues were exposed to cell medium (control) or NMs on one or repeated occasions. Values represent
mean ± SEM (n = 3) unless otherwise stated. Significance indicated by * = p < 0.05 and ** = p < 0.005, when material treatments are compared to
the control. Ψ = p < 0.05 and ΨΨ p < 0.005 is representative of significant difference between values signifying absence and presence of Fpg
enzyme at each given concentration. Φ = p < 0.05 and ΦΦ p < 0.005 is representative of significant difference between single and repeated
exposures. £ signifies n = 2 for that particular treatment. A) ZnO - NM 110 B) Ag – NM 300 C) MWCNT - NM 400 D) TiO2 – NRCWE 002.
SING – single exposure, REP – repeated exposure.
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periments with these levels returning to background
levels over time. This data could suggest that the pro/
anti-inflammatory response in the liver is transient after
removal of the exposure despite that the cytotoxicity in-
dicated by AK release appears to increase over time.
Interestingly a similar IL10 response pattern was noted
from the liver after a low intravenous dose to the same
Ag NM in a mouse model [14]. The multiple exposure
experiments resulted in secretion of IL8 and IL10 from
the tissue at the later time-points, however these levels
did not reach those of the initial exposure in most in-
stances (24 hr). Additionally, significant differences were
found at the latter time-points between the NMs with
higher levels of both cytokines following exposure to the
Ag and ZnO NMs most notable at the higher doses.
This data might indicate there is a degree of sensitiza-
tion and IL10 mediated tolerance in the liver over time.
Another explanation for this decrease of cytokine release
could be cell death over time however as the same gen-
eral pattern is noted for all four NMs including the two
with the very low cytotoxicity this might be unlikely.
The cytokine secretion patterns observed in this studysuggests that future investigations might benefit on con-
centrating on the earlier time points post exposure for
IL8 and IL10 release. Finally, very little up-regulation of
TNF-α, IFN-γ or IL1β was noted from the microtissue
following any of the exposure regiments at the concen-
trations and times investigated within the parameters of
this study. The lack of a TNF-α response is slightly
surprising as the same Ag NM induced an up-regulation
of the cytokine both in a mouse intravenous exposure
model [14] and an ex vivo rat hepatocyte and KC co-
culture model [Filippi C, Kermanizadeh A, Stone V:
Kupffer cell contribution to the hepatic response to
nanomaterials. In preparation].
In order to establish if a single or multiple exposure to
the panel of NMs induced oxidative stress in the micro-
tissue the levels of lipid peroxidation products were de-
termined with an assay that detects reactive carbonyl
compounds such as malondialdehyde. Lipid peroxidation
measurement (oxidative degradation of lipids) is a widely
accepted tool of assessing oxidative stress. Malondialde-
hyde and 4-hydroxynonenal are secondary bi-products,
generated by degradation of lipid hydroperoxides from
the lipid membranes. Once again the single exposure to
AB
Figure 7 Albumin production from primary human liver microtissue following exposure to sub-lethal concentrations of the panel of
engineered NMs. The tissue was exposed to medium (control) or NMs over time. The values are representative of mean ± SEM (n = 3),
significance indicated by ** = p < 0.005, compared to the control. ££ p < 0.005 represents a significant difference between single and repeated
exposures A) single exposure B) repeated exposure.
Figure 8 Basal CYP3A4 activity of 3D human liver microtissue
over 28 days in culture. The liver microtissues were exposed in
GravityTRAP™ plates to midazolam for 24 hr. The supernatant from
the microtissues were analysed for CYP3A4 mediated midazolam-1-
hydroxylation. The values are representative of mean ± SD (n = 3).
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cell membrane lipids. These findings provided corrobor-
ating evidence to the single exposure toxicity and in-
flammation data discussed above. As a contrast however,
repeated exposure to the ZnO and Ag NMs at the
higher concentrations resulted in lipid peroxidation in
the exposed microtissue. These findings seem to suggest
that there is some degree of damage to the tissue follow-
ing the five treatments of the two NMs at the higher
concentrations with oxidative stress being one of the
contributors to these adverse effects (lipid peroxidation
was only measured after five treatments (360 hr)). Previ-
ous studies have shown that NMs are able to induce
lipid peroxidation in hepatocytes as demonstrated in an
experiment with 3 nm Ag NMs which induced a two
fold increase in malondialdehyde in HepG2 cells at a
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Medaka fish after 14 days of treatment [47].
We then investigated genotoxic effects following the
sub-lethal exposure of the four NMs. In this study the
comet assay was utilised as it requires relatively little
sample material and it has become a standard tool in
genetic toxicology of particulate matter [48]. A signifi-
cant increase in strand breaks was noted following ex-
posure to the higher concentrations of all four NMs
with the Ag and ZnO being potent at induction of these
breaks. Similar findings were noted in previous experi-
ments for these NMs in C3A cells following a 24 hr
exposure [49]. The strand breaks were most evident fol-
lowing the repeated exposure in comparison to the sin-
gle exposures. In addition, there was increased levels of
Fpg sensitive sites, indicating that the damage is partially
due to oxidative damage to DNA following exposure to
Ag NMs. Overall this data suggests that the repeated ex-
posure to these NMs (especially the highest concentra-
tions) does indeed induce genotoxicity albeit at fairly
low levels however due to some technical issues (to be
discussed in the following sections) no further conclu-
sions can be made on the findings from the assay.
Albumin is by far the most abundantly produced pro-
tein from the liver and therefore an excellent candidate
for the quantification of normal liver function. Here we
demonstrate that with the exception of repeated treat-
ments of ZnO NM (4 μg/ml – 240 and 360 hr) no change
was noted in albumin production after any of treatments
within this study. We have shown previously that expos-
ure of C3A cells to NMs resulted in no change in the
levels of albumin with the exception of the ZnO NM at
LC50 concentration [24]. In addition a 24 hr intravenous
exposure (24 μg/animal) of Ag NM also did not result in a
significant change in the levels of albumin production
compared to the control animals [14]. This data suggests
that despite of varying degrees of cell death, with the ex-
ception of the ZnO NM after repeated higher level expos-
ure the NMs do not affect hepatocyte function in vitro in
terms of albumin production. The inhibition of albumin
production by the ZnO NMs occurred late after repeated
exposure when cytotoxicity and lipid peroxidation were
overt which might provide an explanation, although simi-
lar toxicity signs of repeated Ag exposure gave no reduc-
tion in albumin production. Albumin is a very important
transport protein for Zn ions in the blood. Another theory
for the observed findings is that the ZnO NMs/Zn2+ are
binding the protein and interfering with the assay, al-
though this does not explain why the effects are only vis-
ible at the latter time points.
The cytochrome P450 superfamily are a number of en-
zymes that are involved in a diverse array of substrate spe-
cific and catalytic activities [28]. The CYP450 enzymes
and their co-factors are embedded in the membrane ofthe endoplasmic reticulum and play a crucial role in the
metabolism of drugs, chemicals and endogenous sub-
strates in the liver [50]. Due to their importance in healthy
functioning hepatocytes this superfamily is usually investi-
gated as markers for normal liver function [51]. Here we
found no decrease in metabolic enzyme CYP3A4 over a
period of 21 days. In addition, these CYP3A4 levels are
comparable to primary hepatocytes.
The use of in vitro hepatocyte models have been bene-
ficial for last two decades in research and various appli-
cation areas. Traditionally, primary hepatocytes appear
as the closest model for the human liver. However, these
cells are typically phenotypically unstable, and have an
extremely short life span. In addition there are signifi-
cant variations between different human donors [52,53].
Hepatocyte cell lines on the other hand are cheap and
much easier to maintain. Hence they are often utilised
as surrogates for human primary hepatocytes. However
their use in absorption, metabolism, excretion and toxicity
studies have been heavily questioned as the basal levels of
their metabolizing enzymes is greatly reduced compared
to primary cells [54]. In addition, most in vitro or ex vivo
nanotoxicological hepatic studies are carried out utilizing
hepatocyte cell lines or primary cultures lacking any non-
parenchymal cells (i.e. KC or SECs). As expressed above
these cells are crucial in terms of the whole organ re-
sponse to NMs. In order to address all of above issues in
this study we have used the InSphero 3D human microtis-
sue. This model offers a stable and functionally active sys-
tem that has some notable and extremely important
advantages over the traditional in vitro hepatic models
[22]. Additionally, this model allows the use of primary
human hepatic cells. This is crucial as most primary hep-
atocyte data generated up to date have utilised cells from
rodents. These inter-species differences could be import-
ant both in terms of nanotoxicology but also in the future
experiments involving NM exploitation for the develop-
ment of field of nanomedicine. The liver cells in this
model are viable for long periods of time which allows for
multiple treatments of NMs over period of weeks which
might be more representative of potential exposure sce-
narios, in vivo toxicity and disease progression. In addition
the hepatocytes in the 3D microtissue model maintain
high levels of the metabolic enzymes for their entire life-
span. As already touched upon, this model also incorpo-
rates the most important hepatic cell populations at the
approximate percentages as would be found in a healthy
liver [22]. Additionally, it has been demonstrated that
there is little variability between individual plates. Finally,
once established this model could significantly reduce the
need for animal testing.
Despite the numerous advantages of the InSphero 3D
human liver microtissue which have been outlined and
discussed above, there are also some limitations to this
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important both in the context of this study and any
future experimentations. The commercially available
model system requires to be purchased and therefore
the price needs to be taken into account in any study de-
sign. In addition, due to the limed volumes of super-
natant there are some restrictions to the assays which
can be utilised. On the same note due to the same quan-
tity issues there is very little room for error. Finally, for
assays which require individual cells (i.e. the comet
assay) an efficient homogenization method is required.
In this study this was a problem which is highlighted in
Figure 5, where some samples did not contain the re-
quired cell numbers hence some replicates are missing.
Thus, further optimization of the homogenization proto-
col may be necessary. Finally, there is a possibility that
due to the lack of blood flow and 3D spheroid structure
not all the inner cells in the microtissue might directly
encounter the NMs. However, since the cytotoxicity was
not only restricted to the outer layer and was distributed
throughout the sphere, it can be argued that some NMs
do penetrate to the central regions of the microtissue.
Conclusions
With the advances in the fields of nanotechnology and
nanomedicine, the potential for public and occupational
exposure is likely to increase, so that there is an urgent
need to consider any potential health consequences as-
sociated with this increased exposure to nanomaterials.
The potential for NM translocation to distal organs fol-
lowing a variety of exposure routes is a realistic pro-
spect, with the liver accumulating a large proportion of
the total or translocated dose. Although advances have
been made in identifying the potential nanotoxicological
effects on the liver, there are still large gaps in the know-
ledge currently available. Therefore, more information is
required for the likely exposure routes and levels,
combined with a mechanistic understanding of the fate
and behaviour of the NMs to determine the biological
activity of the nanomaterial in question [55]. As a means
of better understanding the mechanistics of NM me-
diated hepatotoxicity, we believe that the 3D human
liver microtissues utilised within this study are an
extremely strong candidate for further progression of
in vitro hepatic nanotoxicology.
Methods
Nanomaterials
Nanomaterials were purchased as stated: NM 110 (BASF
Z-Cote; ZnO, uncoated, 100 nm), NM 300 (RAS GmbH;
Ag capped with polyoxylaurat Tween 20 - <20 nm), NM
400 (Nanocyl; entangled MWCNT, diameter 30 nm). All
NMs were sub-sampled under Good Laboratory Practice
conditions and preserved under argon in the dark untiluse. The NRCWE sample was procured by the National Re-
search Centre for the Working Environment (Copenhagen,
Denmark). The NRCWE 002 NM was produced from
the NRCWE 001 (TiO2 rutile 10 nm) as previously de-
scribed [24].
Characterisation of the panel of engineered nanomaterials
Investigated nanomaterials were characterised by a com-
bination of analytical techniques in order to infer primary
physical and chemical properties. Phase compositions and
average crystallites sizes were determined from powder
X-ray diffractograms obtained at room temperature (25°C)
using a Bruker D8 Advanced diffractometer in reflection
mode with Bragg-Brentano geometry. A sealed Cu X-ray
tube was run at 40 kV and 40 mA, wavelength Cu Kα1
1.5406 Å from a primary beam Ge monochromator, fixed
divergence slit 0.2°, step size 0.02, step time 1 s step-1, lin-
ear PSD detector (Lynx-eye) with opening angle 3.3°. The
sample holders used for the reflection data were either a
standard sample holder containing an approximately
2 mm thick sample or a single Si sample holder. The Ag
sample was measured as transmission in a capillary. The
phases were identified by using the EVA 14.0 software
from Bruker AXS. The ratios and size were calculated
using Topas 4.1 from Bruker. The primary and aggregate
size range, shape and crystal structure of the test materials
were determined by 3010 transmission electron micro-
scope operating at 300 kV (Jeol, Japan). Surface areas and
pore volumes were obtained by nitrogen adsorption on a
Micrometritics ASAP2000 Accelerated Surface Area and
Porosimetry System at an adsorption temperature of -196°C,
after pre-treating the sample under high vacuum at 300°C
for 2 hr. In order to assess the dissolution of ZnO and Ag,
the materials were diluted in both ultrapure and filtered
water and complete medium. The analysis was carried out
using an atomic absorption spectrometer (Ag and Zn
Hollow cathode lamp) (Perkin Elmer AAnalyst 200, USA).
A summarised list of the measured physical and chem-
ical properties of the selected NMs has been reproduced
from previously described work [24] (Table 1). Further-
more the hydrodynamic size distributions of the NMs dis-
persed in 3D InSight™ human liver maintenance medium
(InSphero, Switzerland) were determined in the 5-20 μg/
ml concentration range by Nanoparticle Tracking Analysis
(Nanosight LM20, USA) (Table 1).
Morphological characterization of 3D human liver
microtissues
The primary human liver cells were obtained from Biore-
clamation IVT (Brussels, Belgium). In all instances, con-
sent was obtained from all donors. For ethical and privacy
reasons no information was provided which might identify
the donor. For characterisation purposes the microtissues
(Hepatocyte lot IZT; Non Parenchymal Cell lot JJB) were
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(21 days after first NM treatment) culture time into 1.5 ml
tubes, washed with 1 ml PBS and fixated with 4% PFA for
2 hr at room temperature. The specimens were over-layed
with agarose and further processed for paraffin embedding
and histological staining. Next, paraffin sections were
stained with H&E. Immunohistochmistry staining for KCs
was performed with a CD68 antibody (Novocastra Labora-
tories Ltd, USA).
Microtissue maintenance and NM treatment
The human liver microtissue was maintained in human
liver maintenance medium at 37C, 5% CO2. The treat-
ment regiments and the different end points investigated
have been outlined in Table 2.
The Ag NM was supplied in de-ionised water (85%)
with 7% stabilizing agent (ammonium nitrate) and 8%
emulsifiers (4% each of Polyoxyethylene Glycerol Trioleate
and Tween 20). All other materials were supplied as dry
powders. The NMs were dispersed in cell culture grade
water with 2% FCS. The nanomaterials were sonicated for
16 mins without pause following instructions in the proto-
col developed for the EU funded project – ENPRA [56].
Following the sonication step, all samples were immedi-
ately transferred to ice before being diluted in medium just
prior to the experiments. In this study we have utilised five
concentrations for all NMs which included 16, 31.25, 62.5,
125 and 250 μg/ml for the TiO2 (NRCWE 002) and
MWCNT (NM 400) and 0.5, 1, 2, 4 and 8 μg/ml for the
ZnO (NM 110) and Ag (NM 300) which were considered
as non-lethal concentrations to hepatocytes based on pre-
vious studies [24,31]. In this study all concentrations are
expressed as μg/ml. The main reason for this is that the
microtissues are clustered as spheroids and expressing the
treatments as μg/cm2 would not be very relevant or in-
formative. The aim of the repeated exposure experiments
was to assess the adverse effects that might be attributed
to the increased internalisation and accumulation of mate-
rials within the cells over time.
Adenylate kinase assay
The loss of cell membrane integrity was evaluated utilising
a ToxiLight™ bioassay kit (Lonza, USA). Briefly, 20 μl of
cell supernatant was transferred to a luminescence com-
patible plate before the addition of 80 μl of AK detection
buffer. The plates were incubated for 5 mins at room
temperature before the luminescence was measured. These
experiments included the appropriate controls which in-
cluded tissue treated with medium or ToxiLight™ 100%
lysis reagent.
Live/dead staining
In order to get pictorial representations of NM induced
mirotissue cell toxicity a live/death cell staining kit(Abcam, USA) was utilised. The kit uses a cell permeable
green fluorescent dye (Ex/Em - 488/518 nm) to stain live
cells, while dead cells are stained via propidium iodide
(Ex/Em – 488/615 nm). Briefly, microtissue was trans-
ferred to 8 well microscopy chambers (Ibidi, Germany). A
volume of 200 μl of the staining solution was added to all
samples before incubation for 15 mins at 37°C. The tissue
was then observed under a Leica AF6000 inverted wide
field fluorescence microscope (Leica, Germany). In all in-
stances images were captured as a z-stack before undergo-
ing a 3D de-convolution and being represented as a final
3D projection.
Cytokine secretion
The levels of human IL1β, IL8, IL10, IFN-γ and TNF-α
secreted from the microtissue was determined in the cell
supernatant using the BD™ Cytometric Bead Array cyto-
kine flex sets (bead based immunoassay; BD Biosciences,
USA).
Flow cytometry was used to discriminate between differ-
ent bead populations based on size and fluorescence, ac-
cording to the manufacturer’s instructions. The flex sets
employ micro particles with discrete fluorescence inten-
sities to detect soluble analytes (in this case cytokines).
Lipid peroxidation
NM induced oxidative stress (in form of TBARS) was
quantified via a lipid peroxidation kit (Abcam, USA).
Briefly, the microtissue was homogenized on ice in 300 μl
of lysis buffer and centrifuged at 13000 g for 10 mins. This
was followed by the addition of 600 μl of thiobarbituric
acid and an incubation of 95°C for 60 mins. The samples
were cooled on ice for 10 mins and the fluorescence mea-
sured at Ex/Em 520/538 nm. The fluorescence signal was
compared to a standard curve of malondialdehyde (MDA).
Detection of DNA damage in exposed liver microtissue
The Fpg (formamidopyrimidine [fapy] – DNA glycosy-
lase) modified comet assay was utilised to measure DNA
strand breaks and specific oxidatively damaged DNA
such as 7,8-dihydro-8-oxoguanine and ring-opened, 2,6-
diamino-4-hydroxy-5-formamidopyrimidine and 4,6-dia-
mino-5-formamidopyrimidine products, based on the
method described previously [57].
In these experiments two pieces of microtissue were
homogenised, before a mixture of cells and 0.5% low melt-
ing point agarose was added to Gel Bond® films (Lonza,
USA). Following 10 mins of solidification, cells were lysed
overnight at 4°C in lysis buffer (2.5 M NaCl, 100 mM
EDTA, 10 mM Tris-base, pH 10, containing 10% DMSO
and 1% Triton X-100). The films were washed three times
for 5 mins with Fpg-enzyme buffer (40 mM HEPES,
100 mM KCl, 0.5 mM EDTA, 0.2 mg/ml BSA - pH 8),
covered with 100 μl of either buffer or Fpg (Fpg enzyme
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Oslo, Norway) in buffer (1:30), sealed with a cover slip and
incubated for 30 mins at 37°C. Fpg cleaves DNA at loca-
tions of oxidation leading to a greater tail for cells exhibit-
ing oxidative DNA damage [58]. The films were then
transferred into chilled electrophoresis tanks. After alka-
line unwinding (pH 13) for 20 mins, electrophoresis was
performed for 10 mins at 270 mA, 24 V. The slides were
neutralized three times for 5 mins using a neutralization
buffer (0.4 M TrisBase, pH 7.5). Before the final count the
films were dried and stained with GelRed (2 in 10000 dilu-
tion, 40 μl per slide). The percentage of DNA in the tail
was measured using an automatic image analyser (Comet
Assay IV; Perceptive Instruments, UK) connected to a
fluorescence microscope. The images were captured using
a stingray (F-033B/C) black and white video camera. In all
instances a total of 50 cells were analysed per gel with the
mean used as the experimental unit in the statistical ana-
lysis. A reference control sample was utilised in each ex-
periments (corresponding to each electrophoresis) that
included undamaged or photosensitizer Ro19-8022 and
white light exposed peripheral mononuclear blood cells,
which generates Fpg sensitive sites. The Ro19-8022 was a
kind gift from F. Hoffmann (Roche, Switzerland).
Albumin production
After exposure the supernatants (from both the control
and treated cells as described above) were collected and
stored at -80°C. The supernatants were centrifuged at
1000 g, were diluted two fold and albumin levels deter-
mined by ELISA according to the manufacturer’s in-
structions (Bethyl laboratories, USA).
CYP3A4 measurements
3D InSight™ human liver microtissues were incubated in
medium containing midazolam as a probe substrate for
CYP3A4 activity. The amount of midazolam-1’-hydroxyl-
ation was assessed after 24 hr incubation at culture days 7
and 28. For all time points three replicates single microtis-
sues were analysed for each time point. After the 24 hr in-
cubation period with midazolam, the supernatants were
harvested and stored at -80°C. The quantification of
midazolam-1-hydroxylation in cell culture supernatants
was performed by Pharmacelsus® (GmbH, Germany).
Statistical analysis
All data are expressed as mean ± standard error of the
mean (SEM). For statistical analysis, the experimental re-
sults were compared to their corresponding control
values using full-factorial ANOVA with Tukey’s multiple
comparison. All statistical analysis was carried out utiliz-
ing Minitab 17. A p value of <0.05 was considered to be
significant. All experiments were repeated a minimum of
three times unless otherwise stated.Competing interests
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